1,097
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Risk factors for colorectal cancer in man induce aberrant crypt foci in rats: Preliminary findings

, , , , , , , , , , , , & show all
Pages 94-104 | Received 02 Jul 2014, Accepted 15 Sep 2015, Published online: 28 Dec 2015

References

  • World Cancer Research Fund/American Institute for Cancer Research: Food, Nutrition, Physical Activity and the Prevention of Cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 2007. Continuous updates are available at http://www.dietandcancerreport.org/cup/index.php
  • Jenab M, Buenoe-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, et al.: Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in european populations:A nested case-control study. BMJ 340, b5500, 2010.
  • Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, et al.: A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 99, 1120–1129, 2007.
  • Wargovich MJ, Allnutt D, Palmer C, Anaya P, and Stephens LC: Inhibition of the promotional phase of azoxymethane-induced colon carcinogenesis in the F344 rat by calcium lactate: Effect of simulating two human nutrient density levels. Cancer Lett 53, 17–25, 1990.
  • Gacs G, and Barltrop D: Significance of ca-soap formation for calcium absorption in the rat. Gut 18, 64–68, 1977.
  • Newmark HL, Wargovich MJ, and Bruce WR: Ions and neoplastic development. In: Large Bowel Cancer: Clinical and Basic Science Research. Cancer Research Monographs 3, Mastromarino AJ and Brattain MG (eds). New York: Praeger Scientific Press, 1985, pp. 102–130.
  • Newmark HL, Lipkin M, and Maheshwari N: Colonic hyperproliferation induced in rats and mice by nutritional-stress diets containing four components of a human Western-style diet (series 2). Am J Clin Nutr 54(1 Suppl), 209S–214S, 1991.
  • Newmark HL, Yang K, Lipkin M, Kopelovich L, Liu Y, et al.: A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis 22, 1871–1875, 2001.
  • Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, et al.: Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis 30, 88–92, 2009.
  • Pierre F, Tache S, Petit CR, Van der Meer R, and Corpet DE: Meat and cancer: Haemoglobin and haemin in a low-calcium diet promote colorectal carcinogenesis at the aberrant crypt stage in rats. Carcinogenesis 24, 1683–1690, 2003.
  • Pierre F, Peiro G, Taché S, Cross AJ, Bingham SA, et al.: New marker of colon cancer risk associated with heme intake: 1,4-dihydroxynonane mercapturic acid. Cancer Epidemiol Biomarkers Prev 15, 2274–2279, 2006.
  • Tran TT, Naigamwalla D, Oprescu AI, Lam L, McKeown-Eyssen G, et al.: Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology 147, 1830–1837, 2006.
  • McKeown-Eyssen G, Bruce J, Lee O, O'Brien PJ, and Bruce WR: Lifestyle, endogenous toxins and colorectal cancer risk. In: Endogenous Toxins: targets for disease treatment and prevention, O'Brien PJ and Bruce WR (eds.). Weinheim: Wiley-VCH, 2010, pp. 673–694.
  • Ma TY, Tran D, Hoa N, Nguyen D, Merryfield M, and Tarnawski A: Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement. Microsc Res Tech 51, 156–168, 2000.
  • Carrier J, Adhgassi G, Platt I, Cullen J, and Allard JP: Effect of oral iron supplementation on oxidative stress and inflammation in rats with induced colitis. Aliment Pharmacol Ther 15, 1989–1999, 2001.
  • O'Brien PJ, Feng CY, Lee O, Rhea M, Bruce J, et al.: Fructose-derived endogenous toxins. In: Endogenous Toxins: targets for disease treatment and prevention, O'Brien PJ and Bruce WR (eds.). Weinheim: Wiley-VCH, 2010, pp. 173–212.
  • Fujita Y, Wakabayashi K, Nagao M, and Sugimura T: Implication of hydrogen peroxide in the mutagenicity of coffee. Mutat Res 144, 227–230, 1985.
  • Lee O, Bruce WR, Dong Q, Bruce J, Mehta R, et al.: Fructose and carbonyl metabolites as endogenous toxins. Chem Biol Interact 178, 332–339, 2009.
  • Benov L, and Beema AF: Superoxide-dependence of the short chain sugars-induced mutagenesis. Free Radic Biol Med 34, 429–433, 2003.
  • Prestwich EG, and Dedon PC: Endogenus DNA damage. In: Endogenous Toxins: targets for disease treatment and prevention, O'Brien PJ and Bruce WR (eds.). Weinheim, Wiley-VCH, 2010, pp. 5–42.
  • Bird RP: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett 37, 147–151, 1987.
  • Whiteley LO, Hudson L, Jr., and Pretlow TP: Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen. Toxicol Pathol 24, 681–689, 1996.
  • Roncucci L, Stamp D, Medline A, Cullen JB, and Bruce WR. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 22, 287–294, 1991.
  • Bjerknes M, and Cheng H: Methods for the isolation of intact epithelium from the mouse intestine. Anat Rec 199, 565–574, 1981.
  • Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, et al.: Measurement of protein using bicinchoninic acid. Anal Biochem 150, 76–85, 1985.
  • Messner DJ, Sivam G, and Kowdley KV. Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells. Liver Int 29, 63–72, 2009.
  • Pereira S, Yu WQ, Frigolet ME, Beaudry JL, Shpilberg Y, Park E, et al.: Duration of rise in free fatty acids determines salicylate's effect on hepatic insulin sensitivity. J Endocrinol 217, 31–43, 2013.
  • Yagi K: Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol 108, 101–106, 1998.
  • Shamsi FA, Partal A, Sady C, Glomb MA, and Nagaraj RH: Immunological evidence for methylglyoxal-derived modifications in vivo. Determination of antigenic epitopes. J Biol Chem 273, 6928–6936, 1998.
  • Femia AP, Giannini A, Fazi M, Tarquini E, Salvadori M, et al.: Identification of mucin depleted foci in the human colon. Cancer Prev Res (Phila) 1, 562–567, 2008.
  • Jass JR, Whitehall VLJ, Young J, and Leggett BA: Emerging concepts in colorectal neoplasia. Gastroenterology 123, 862–876, 2002.
  • Adler DG, Gostout CJ, Sorbi D, Burgart LJ, Wang L, et al.: Endoscopic identification and quantification of aberrant crypt foci in the human colon. Gastrointest Endosc 56, 657–662, 2002.
  • Rudolf RE, Dominitz JA, Lampe JW, Levy L, Qu P, et al. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer Epidemiol Biomarkers Prev 14, 605–608, 2005.
  • Sakai E, Takahashi H, Kato S, Uchiyama T, Hosono K, et al.: Investigation of the prevelance and number of aberrant crypt foci associated with human colorectal neoplasm. Cancer Epidemiology Biomarkers Prev 20, 1918–1924, 2011.
  • Anderson JC, Swede H, Rustagi T, Protiva P, Pleau D, et al.: Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy. Cancer Causes Control 23, 355–361, 2012.
  • Mutch MG, Schoen RE, Fleshman JW, Rall CJN, Dry S, et al.: A multicenter study of prevelance and risk factors for aberrant crypt foci. Clin Gastroent Hepatol 7, 568–574, 2009.
  • Pinsky PF, Fleshman J, Mutch M, Rall C, Charabaty A, et al.: One year recurrence of aberrant crypt foci. Cancer Prev Res 3, 839–843, 2010.
  • Shpitz B, Hay K, Medline A, Bruce WR, Bull SB, et al.: Natural history of aberrant crypt foci. A surgical approach. Dis Colon Rectum 39, 763–767, 1996.
  • Bjerknes M, and Cheng H: Colossal crypts bordering colon adenomas in Apc(Min) mice express full-length Apc. Am J Pathol 154, 1831–1834, 1999.
  • Glick SN, Teplick SK, and Ross WM: Colonic lymphoid follicles associated with colonic neoplasms. Radiology 168, 603–607, 1988.
  • Shpitz B, Bomstein Y, Mekori Y, Cohen R, Kaufman Z, et al.: Aberrant crypt foci in human colons: distribution and histomorphologic characteristics. Hum Pathol 29, 469–475, 1998.
  • Hamdani G, Gabet Y, Rachmilewitz D, Karmeli F, Bab I, et al.: Dextran sodium sulfate-induced colitis causes rapid bone loss in mice. Bone 43, 945–950, 2008.
  • Pele LC, Thoree V, Mustafa F, He S, Tsaprouni L, et al.: Low dietary calcium levels modulate mucosal caspase expression and increase disease activity in mice with dextran sulfate sodium induced colitis. J Nutr 137, 2475–2480, 2007.
  • Joshi YM, and Kwak JC: The binding of divalent metal ions to polyelectrolytes in mixed counterion systems. II. dextransulfate-Mg2+ and dextransulfate-Ca2+ in solutions containing added NaCl or KCl. Biophys Chem 13, 65–75, 1981.
  • Maki H, and Miyajima T: Linear charge density dependence of polyelectrolyte phase volume of ionic dextransulfate as a strong acidic polyion. Macromolecules 44, 5027–5035, 2011.
  • Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, and Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694–702, 1990.
  • Cooper HS, Murthy SN, Shah RS, and Sedergran DJ: Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69, 238–249, 1993.
  • Lien YH: Are oral sodium phosphate products for bowel cleansing safe for the general population? Am J Med 121, 931–932, 2008.
  • Driman DK, and Preiksaitis HG: Colorectal inflammation and increased cell proliferation associated with oral sodium phosphate bowel preparation solution. Hum Pathol 29, 972–978, 1998.
  • Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, et al.: Cancer genome landscapes. Science 339, 1546–1548, 2013.
  • DaCosta RS, Andersson H, Cirocco M, Marcon NE, and Wilson BC: Autofluorescence characterisation of isolated whole crypts and primary cultured human epithelial cells from normal, hyperplastic, and adenomatous colonic mucosa. J Clin Pathol 58, 766–774, 2005.
  • Dedon PC, and Tannenbaum SR: Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 423, 12–22, 2004.